Search for content, post, videos

Modus has secured access to bridge financing of up to 7 MSEK

Modus Therapeutics secures access to bridge financing from longstanding investor Karolinska Development. Access to this funding ensures that momentum of clinical development of Modus’ lead asset, sevuparin, will be enhanced while the company continues to explore licensing and partnership opport
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.